Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianxiang Lin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Molecular Cell|May 4, 2023
A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibilityJunfan Guo, Wenxia Yu, Min Li, et al.
Nature Communications|March 16, 2021
Author Correction: High-resolution annotation of the mouse preimplantation embryo transcriptome using long-read sequencingYunbo Qiao, Chao Ren, Shisheng Huang, et al.
Nature Communications|May 29, 2020
High-resolution annotation of the mouse preimplantation embryo transcriptome using long-read sequencingYunbo Qiao, Chao Ren, Shisheng Huang, et al.
Nature Communications|July 23, 2021
Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasisBo Ye, Dandan Fan, Weiwei Xiong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2025
Enhancer RNA Transcriptome-Wide Association Study Reveals a Distinctive Class of Pan-Cancer Susceptibility eRNAsWenyan Chen, Zeyang Wang, Yinuo Wang, et al.
Vaccine|April 14, 2025
Corrigendum to "Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)" [Vaccine 49 (7) (2025) 126815]Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Vaccine|February 16, 2025
Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Nature Communications|June 17, 2026
Guide RNA reprogramming facilitates minimized tracrRNA-dependent off-target and versatile CRISPR/Cas9 engineeringWenxia Yu, Jun Chen, Junfan Guo, et al.
Human Vaccines & Immunotherapeutics|July 4, 2023
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian childrenSamba O Sow, Milagritos D Tapia, Fadima Cheick Haidara, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Cell|May 4, 2023
A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibilityJunfan Guo, Wenxia Yu, Min Li, et al.
Nature Communications|March 16, 2021
Author Correction: High-resolution annotation of the mouse preimplantation embryo transcriptome using long-read sequencingYunbo Qiao, Chao Ren, Shisheng Huang, et al.
Nature Communications|May 29, 2020
High-resolution annotation of the mouse preimplantation embryo transcriptome using long-read sequencingYunbo Qiao, Chao Ren, Shisheng Huang, et al.
Nature Communications|July 23, 2021
Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasisBo Ye, Dandan Fan, Weiwei Xiong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2025
Enhancer RNA Transcriptome-Wide Association Study Reveals a Distinctive Class of Pan-Cancer Susceptibility eRNAsWenyan Chen, Zeyang Wang, Yinuo Wang, et al.
Vaccine|April 14, 2025
Corrigendum to "Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)" [Vaccine 49 (7) (2025) 126815]Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Vaccine|February 16, 2025
Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Nature Communications|June 17, 2026
Guide RNA reprogramming facilitates minimized tracrRNA-dependent off-target and versatile CRISPR/Cas9 engineeringWenxia Yu, Jun Chen, Junfan Guo, et al.
Human Vaccines & Immunotherapeutics|July 4, 2023
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian childrenSamba O Sow, Milagritos D Tapia, Fadima Cheick Haidara, et al.
Pageof 2